迪哲医药(688192.SH)：前三季度净亏损5.8亿元

Core Insights - Dige Pharmaceutical (688192.SH) reported a total revenue of 586 million yuan for the first three quarters of 2025, representing a year-on-year increase of 73.23% [1] - The net profit attributable to shareholders of the parent company was -580 million yuan, which is a deterioration of 21.4873 million yuan compared to the same period last year [1] - The basic earnings per share stood at -1.32 yuan [1]